Skip to main content

Table 5 Efficiency frontier and summary of cost-effectiveness results

From: Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France

Efficiency frontier (on-site reading)

MRI with DW-MRI

NaF-PET/CT

FCH-PET/CT

Life expectancy (years)

5.50

5.78

6.11

QALYs

4.45

4.67

4.93

Cost in Euros

22,160

22,385

22,641

ICER: Euros per QALY gained

 

1002

993

Efficiency frontier (central reading)

NaF-PET/CT

MRI with DW-MRI

FCH-PET/CT

Life expectancy (years)

5.87

5.87

6.03

QALYs

4.73

4.73

4.87

Cost in Euros

22,481

22,063

22,729

ICER: Euros per QALY gained

dominated

 

5055

  1. ICER Incremental cost-effectiveness ration; QALYs Quality-adjusted life expectancy